Fifth Third Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Fifth Third Wealth Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$627K	Buy	7,268 +132	+2%	+$11.7K	0.02%	447
2026 Q2	$646K	Buy	7,136 +1,465	+26%	+$123K	0.02%	410
2026 Q1	$454K	Buy	5,671 +636	+13%	+$52.4K	0.02%	461
2025 Q4	$429K	Sell	5,035 -243	-5%	-$19.9K	0.02%	442
2025 Q3	$410K	Sell	5,278 -131	-2%	-$10.2K	0.02%	446
2025 Q2	$423K	Sell	5,409 -287	-5%	-$21.4K	0.02%	409
2025 Q1	$413K	Buy	5,696 +112	+2%	+$8.02K	0.02%	383
2024 Q4	$413K	Buy	5,584 +278	+5%	+$19.5K	0.02%	384
2024 Q3	$350K	Sell	5,306 -493	-9%	-$35.8K	0.02%	406
2024 Q2	$536K	Buy	+5,799	New	+$514K	0.04%	257

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Fifth Third Wealth Advisors's EW Position: Q3 2026 in Review

Fifth Third Wealth Advisors increased its Edwards Lifesciences (EW) stake by 1.8% in Q3 2026, buying an estimated $11.7K and bringing the position to 7,268 shares worth $627K. The position accounts for 0.02% of the portfolio, ranked #447.

Fifth Third Wealth Advisors first reported a position in EW in Q2 2024 and has held it in 10 quarters since. The position peaked at $646K in Q2 2026. 326 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Fifth Third Wealth Advisors held 7,268 shares of Edwards Lifesciences worth $627K as of Q3 2026.
Fifth Third Wealth Advisors bought 132 Edwards Lifesciences shares in Q3 2026, an estimated $11.7K.
Edwards Lifesciences made up 0.02% of Fifth Third Wealth Advisors's portfolio in Q3 2026, its #447 holding.
Fifth Third Wealth Advisors first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 10 quarters since.
Fifth Third Wealth Advisors's Edwards Lifesciences position peaked at $646K in Q2 2026.
326 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.